
ICON Public Limited Company ICLR
€ 86.69
0.19%
Geschäftsbericht 2024
hinzugefügt 14.03.2026
ICON Public Limited Company Betriebsaufwand 2011-2026 | ICLR
Betriebsaufwand Jährlich ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 408 M | 398 M | 392 M | 385 M | 385 M | 384 M | 389 M | 360 M | 324 M | 295 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 408 M | 295 M | 372 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Biomerica
BMRA
|
5.64 M | $ 2.13 | - | $ 4.89 M | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
45.3 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
123 M | $ 74.43 | -1.72 % | $ 5.02 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
607 M | $ 158.47 | 0.24 % | $ 7.85 B | ||
|
IQVIA Holdings
IQV
|
2.94 B | $ 165.48 | -0.92 % | $ 28.4 B | ||
|
Medpace Holdings
MEDP
|
118 M | $ 457.54 | 0.13 % | $ 13.2 B | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
343 M | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
41.3 M | $ 1.21 | -17.14 % | $ 6.59 M | ||
|
Mettler-Toledo International
MTD
|
1.01 B | $ 1 243.86 | 0.28 % | $ 25.6 B | ||
|
Interpace Biosciences
IDXG
|
21.8 M | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
IDEXX Laboratories
IDXX
|
1.3 B | $ 571.85 | -1.15 % | $ 46 B | ||
|
Illumina
ILMN
|
3.69 B | $ 125.07 | 1.03 % | $ 19.9 B | ||
|
Myriad Genetics
MYGN
|
964 M | $ 4.68 | 0.54 % | $ 433 M | ||
|
Guardant Health
GH
|
226 M | $ 83.91 | -1.17 % | $ 10.5 B | ||
|
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B | ||
|
National Research Corporation
NRC
|
38.5 M | $ 17.51 | - | $ 392 M | ||
|
Pacific Biosciences of California
PACB
|
600 M | $ 1.36 | -2.52 % | $ 408 M | ||
|
Celcuity
CELC
|
113 M | $ 101.4 | -5.01 % | $ 4 B | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 263.49 | -0.37 % | $ 21.9 B | ||
|
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
13.6 M | $ 26.85 | -0.3 % | $ 34.8 M | ||
|
ENDRA Life Sciences
NDRA
|
10.8 M | $ 3.41 | -2.16 % | $ 1.83 M | ||
|
NeoGenomics
NEO
|
430 M | $ 7.93 | -2.1 % | $ 1.02 B | ||
|
Personalis
PSNL
|
44.5 M | $ 7.52 | -1.18 % | $ 446 M | ||
|
Natera
NTRA
|
258 M | $ 194.93 | -2.58 % | $ 19.2 B | ||
|
RadNet
RDNT
|
1.98 B | $ 59.45 | -3.72 % | $ 4.47 B | ||
|
CareDx, Inc
CDNA
|
411 M | $ 17.37 | -1.08 % | $ 926 M | ||
|
OPKO Health
OPK
|
217 M | $ 1.14 | -1.3 % | $ 791 M | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 25.36 | -1.51 % | $ 704 M | ||
|
Senseonics Holdings
SENS
|
61.8 M | $ 6.71 | 1.36 % | $ 280 M | ||
|
Sotera Health Company
SHC
|
309 M | $ 13.8 | -0.61 % | $ 3.92 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 195.47 | -0.08 % | $ 21.7 B | ||
|
DarioHealth Corp.
DRIO
|
49.3 M | $ 7.37 | -1.73 % | $ 29.4 M | ||
|
DexCom
DXCM
|
1.89 B | $ 66.5 | 0.85 % | $ 25.9 B |